What the GLP-1 Bone Loss Research Means for Women Over 40 Specifically The research on GLP-1 therapy and bone loss is generating particular clinical attention in the context of women over 40 - and specifically women in perimenopause and menopause - because this population already faces a well-documented accelerated rate of bone density loss driven by estrogen decline
Semaglutide-based clinical evidence from a post hoc analysis of the SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) trials (SUSTAIN 15
Prescription Standards for B12 Injections Getting a Vitamin B12 injection prescription involves careful steps
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
[but, weve just assumed this was due to reduced intake] of dietary cholesterol and saturated fat But, what these researchers found was that within 24 hours of carnitine consumptioneating a sirloin steak, taking a carnitine supplementcertain gut bacteria metabolize the carnitine to a toxic substance called trimethylamine, which then gets oxidized in our liver to TMAO (trimethylamine-n-oxide), which then circulates throughout our bloodstream
First, the effect is selective: visceral fat fell, but pinchable fat and total weight barely changed